/PRNewswire/ Atlantic Coastal Acquisition Corp. (NASDAQ: ACAH) (the "Company"), a special purpose acquisition corporation, today announced that it will.
NEW YORK, Aug. 18, 2023 /PRNewswire/ Atlantic Coastal Acquisition Corp. , a special purpose acquisition corporation, today announced that it will redeem all of its outstanding shares of Class A.
Verve Therapeutics, Inc. (NASDAQ:VERV – Get Rating) has earned a consensus rating of “Buy” from the eight ratings firms that are presently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 month price objective among […]
Verve Therapeutics (NASDAQ:VERV – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Friday, Zacks.com reports. According to Zacks, “Verve Therapeutics is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management […]